| 1 |
35346999 | CJ14939, a Novel JAK Inhibitor, Increases Oxaliplatin-induced Cell Death Through JAK/STAT Pathway in Colorectal Cancer. | 2022 Apr |
1 |
| 2 |
35501324 | UHMK1 aids colorectal cancer cell proliferation and chemoresistance through augmenting IL-6/STAT3 signaling. | 2022 May 2 |
1 |
| 3 |
34351659 | The effect and mechanism of erianin on the reversal of oxaliplatin resistance in human colon cancer cells. | 2021 Dec |
2 |
| 4 |
30736824 | Bazedoxifene as a novel GP130 inhibitor for Colon Cancer therapy. | 2019 Feb 8 |
1 |
| 5 |
30042932 | The Interplay of Notch Signaling and STAT3 in TLR-Activated Human Primary Monocytes. | 2018 |
1 |
| 6 |
30410004 | Different responses of colorectal cancer cells to alternative sequences of cetuximab and oxaliplatin. | 2018 Nov 8 |
1 |
| 7 |
28356957 | Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway. | 2017 Feb |
4 |
| 8 |
29166835 | Activation of STAT3-mediated CXCL12 up-regulation in the dorsal root ganglion contributes to oxaliplatin-induced chronic pain. | 2017 Jan-Dec |
4 |
| 9 |
23969971 | Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer. | 2013 Aug |
1 |
| 10 |
24098947 | RKIP phosphorylation and STAT3 activation is inhibited by oxaliplatin and camptothecin and are associated with poor prognosis in stage II colon cancer patients. | 2013 Oct 8 |
2 |
| 11 |
22193989 | The chemotherapeutic drug oxaliplatin differentially affects blood DC function dependent on environmental cues. | 2012 Jul |
1 |